On 10/2/2009
heart and soul wrote:
I think, knowing our NO, it will be CPT-11 and Avastin. But very sadly it means that Andy probably can't move back to Asheville for the winter and have even a short stretch of 'normal'.
Thanks for your goodness. Be well.
Love, Sarah
Sarah,
I'm sorry to hear about the reoccurence. My heart goes out to you. I'm not sure if you read about this treatment. NovoCure, Ltd., a privately held medical device company focused on developing the Novo-TTF device, a non-invasive portable medical device for the treatment of cancer.
The Novo-TTF device is a unique cancer treatment that uses specially tuned, low intensity electrical fields (Tumor Treating Fields or TTFields) to disrupt cell division. Rapidly dividing cancerous cells are affected by the TTFields , causing them to either break apart or not divide properly, while healthy, non-dividing cells are not affected, yielding a targeted treatment with minimal side effects. The fields are applied to the tumor region using non-invasive, insulated electrodes placed on a patient's skin. The electrodes, which look like bandages, are attached by wires to a battery operated, portable device that generates the fields.
INITIATION OF CLINICAL TRIAL FOR NEWLY DIAGNOSED GBM
The Novo-TTF device has been tested in more than 175 patients with various types of cancers including recurrent and newly-diagnosed glioblastoma multiforme (GBM), breast cancer and lung cancer.
NovoCure recently completed enrollment of a 236-patient, multi-center, randomized Pivotal clinical trial studying the safety and efficacy of the Novo-TTF device treating patients with recurrent GBM compared to standard-of-care chemotherapy.
Details about the newly diagnosed GBM trial including trial locations can be found on the NovoCure website (www.novocuretrial.com).
Sister GBM since 7/09